Gayko Urte 4
4 · Summit Therapeutics Inc. · Filed Apr 26, 2022
Insider Transaction Report
Form 4
Gayko Urte
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-25+400,000→ 400,000 totalExercise: $1.93Exp: 2032-04-25→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years.
- [F2]Not applicable.